![EU reclassification (Rx to OTC switch) regulatory framework – what are the key challenges for industry and how might these be overcome? Part 2 | Journal | Regulatory Rapporteur EU reclassification (Rx to OTC switch) regulatory framework – what are the key challenges for industry and how might these be overcome? Part 2 | Journal | Regulatory Rapporteur](https://ds982gbwnvyso.cloudfront.net/Pictures/1024x536/3/1/2/312_rxtootcfig1_467036.jpg)
EU reclassification (Rx to OTC switch) regulatory framework – what are the key challenges for industry and how might these be overcome? Part 2 | Journal | Regulatory Rapporteur
![Socioeconomic Considerations in Choosing and Evaluating Candidates for RX -to-OTC Switch - Selfcare Journal Socioeconomic Considerations in Choosing and Evaluating Candidates for RX -to-OTC Switch - Selfcare Journal](https://selfcarejournal.com/wp-content/uploads/2022/09/Bauer.-Figure-2-300x297.jpg)
Socioeconomic Considerations in Choosing and Evaluating Candidates for RX -to-OTC Switch - Selfcare Journal
![Which OTC drug product categories and drug classes have experienced the most switches in recent year by Market Intel Reports - Issuu Which OTC drug product categories and drug classes have experienced the most switches in recent year by Market Intel Reports - Issuu](https://image.isu.pub/160218073021-b47a6069fcb843730ca371453f131977/jpg/page_1.jpg)
Which OTC drug product categories and drug classes have experienced the most switches in recent year by Market Intel Reports - Issuu
![Rx-to-OTC Switch: An Important Enabler of Self-Care and a Growth Engine for the OTC Market | IRI Publications Rx-to-OTC Switch: An Important Enabler of Self-Care and a Growth Engine for the OTC Market | IRI Publications](https://www.iriworldwide.com/IRI/media/Library/rx-to-otc-thumb358x300.jpg?ext=.jpg)